|

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

RECRUITINGN/ASponsored by Uppsala University
Actively Recruiting
PhaseN/A
SponsorUppsala University
Started2025-03-20
Est. completion2030-06-30
Eligibility
Age50 Years – 80 Years
Healthy vol.Accepted

Summary

Diet can play a key role in atherosclerosis and coronary heart disease (CHD), but little interventional data exists, and the mediators of possible anti-atherosclerotic effects of diet are unclear. The investigators will investigate if a healthy Nordic diet (HND) reduces plaque volume, coronary artery calcification (CAC), and plaque inflammation (FAI) in CHD, and examine if changes in gut microbiota may be linked to plaque progression over time. The investigators will also explore if the diet response can be predicted by the metabolic phenotype. In total 150 CHD patients is randomized to a HND rich in unsaturated fat and fibre from plants, or to a "usual care diet" for 18 months. Plaque volume and composition is assessed by CT, and fecal microbiota composition is determined by deep metagenome shotgun sequencing. CHD and metabolic risk factors, liver fat, muscle fat and biomarkers of diet adherence (plasma fatty acids, whole-grain metabolites) are measured. Machine-learning is used to identify diet "responders" on plaque progression, based on the individual microbiome and metabolome. If a HND reduces plaque progression, this would be novel information of clinical importance. Also, if the diet alters microbiota that are linked to plaque progression, this would be of high scientific interest. Finally, potential prediction of the diet-response would open up for more personalized treatment of atherosclerosis.

Eligibility

Age: 50 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Men and women
* Diagnosis with MI from 2 weeks after diagnosis and with maximum 6 months after diagnosis
* Diagnosis with CCS (e.g. stable angina pectoris)
* Ages 50 to 80 years
* BMI 25-40.

Exclusion Criteria:

* Severe heart failure (NYHA classes III, IV)
* Alcohol intake \>20g/day
* Unwillingness to follow a new prescribed diet for 18 months
* Other diseases implying a short estimated life expectancy (e.g. severe malignant or kidney or liver disease, as judged by consenting physician).

Conditions9

Chronic Coronary SyndromeCoronary ArteriosclerosisCoronary DiseaseDiabetesHeart DiseaseLiver DiseaseMASLDMyocardial InfarctionType 2 Diabetes

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.